- Home
- VCSA vs OMIC Comparison
VCSA vs OMIC Comparison
Compare VCSA & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCSA
- OMIC
- Stock Information
- Founded
- VCSA 2009
- OMIC 2016
- Country
- VCSA United States
- OMIC United States
- Employees
- VCSA N/A
- OMIC N/A
- Industry
- VCSA Computer Software: Prepackaged Software
- OMIC Medical/Dental Instruments
- Sector
- VCSA Technology
- OMIC Health Care
- Exchange
- VCSA Nasdaq
- OMIC Nasdaq
- Market Cap
- VCSA 38.6M
- OMIC 34.9M
- IPO Year
- VCSA N/A
- OMIC 2021
- Fundamental
- Price
- VCSA $3.34
- OMIC $19.55
- Analyst Decision
- VCSA Buy
- OMIC Hold
- Analyst Count
- VCSA 4
- OMIC 2
- Target Price
- VCSA $6.08
- OMIC $10.75
- AVG Volume (30 Days)
- VCSA 79.6K
- OMIC 10.7K
- Earning Date
- VCSA 11-07-2024
- OMIC 11-12-2024
- Dividend Yield
- VCSA N/A
- OMIC N/A
- EPS Growth
- VCSA N/A
- OMIC N/A
- EPS
- VCSA N/A
- OMIC N/A
- Revenue
- VCSA $949,936,000.00
- OMIC $2,667,000.00
- Revenue This Year
- VCSA N/A
- OMIC $3.98
- Revenue Next Year
- VCSA N/A
- OMIC $242.05
- P/E Ratio
- VCSA N/A
- OMIC N/A
- Revenue Growth
- VCSA N/A
- OMIC 2.77
- 52 Week Low
- VCSA $2.07
- OMIC $5.34
- 52 Week High
- VCSA $11.70
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- VCSA 43.35
- OMIC 45.49
- Support Level
- VCSA $3.75
- OMIC $19.07
- Resistance Level
- VCSA $4.79
- OMIC $21.90
- Average True Range (ATR)
- VCSA 0.41
- OMIC 0.91
- MACD
- VCSA -0.13
- OMIC -0.28
- Stochastic Oscillator
- VCSA 0.00
- OMIC 21.67
About VCSA Vacasa Inc.
Vacasa Inc is a vacation rental management platform in North America, transforming the vacation rental experience by integrating purpose-built technology with expert local and national teams.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.